FDA Inspection 964119 — Washington Hospital Center Transfusion Service
The FDA completed an inspection of Washington Hospital Center Transfusion Service on Mar 8, 2016 in Washington, DC. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Mar 8, 2016
- Fiscal Year
- 2016
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Washington, DC (United States)